You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RXRX Sale Disclosure
Bumpus Namandje · SEC Form 4 · Filed Jun 4, 2026
Sale
Calculated transaction value
$15.53K
Bumpus Namandje Director
RXRX
Transaction date
Jun 3, 2026
Public filing date
Jun 4, 2026
Filing lag
Filed 1 day later
RXRX daily price context
Close on/before transaction
$3.47
Jun 3, 2026
First close after public filing
$3.31
Jun 5, 2026
30-day return after filing
+19.46%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 4,386 shares @ $3.54
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002060594-26-000003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$15.53K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Sale | Jun 3, 2026 | $15.53K |